Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 293(29): 11553-11563, 2018 07 20.
Article in English | MEDLINE | ID: mdl-29884772

ABSTRACT

PEX1 and PEX6 are two members of the ATPases associated with diverse cellular activities (AAA) family and the core components of the receptor export module of the peroxisomal matrix protein import machinery. Their role is to extract monoubiquitinated PEX5, the peroxisomal protein-shuttling receptor, from the peroxisomal membrane docking/translocation module (DTM), so that a new cycle of protein transportation can start. Recent data have shown that PEX1 and PEX6 form a heterohexameric complex that unfolds substrates by processive threading. However, whether the natural substrate of the PEX1-PEX6 complex is monoubiquitinated PEX5 (Ub-PEX5) itself or some Ub-PEX5-interacting component(s) of the DTM remains unknown. In this work, we used an established cell-free in vitro system coupled with photoaffinity cross-linking and protein PEGylation assays to address this problem. We provide evidence suggesting that DTM-embedded Ub-PEX5 interacts directly with both PEX1 and PEX6 through its ubiquitin moiety and that the PEX5 polypeptide chain is globally unfolded during the ATP-dependent extraction event. These findings strongly suggest that DTM-embedded Ub-PEX5 is a bona fide substrate of the PEX1-PEX6 complex.


Subject(s)
ATPases Associated with Diverse Cellular Activities/metabolism , Cytosol/metabolism , Membrane Proteins/metabolism , Peroxisome-Targeting Signal 1 Receptor/metabolism , Protein Interaction Maps , Humans , Models, Molecular , Peroxisome-Targeting Signal 1 Receptor/chemistry , Peroxisomes/metabolism , Protein Transport , Protein Unfolding , Ubiquitin/metabolism , Ubiquitination
2.
Adv Exp Med Biol ; 1059: 373-394, 2018.
Article in English | MEDLINE | ID: mdl-29736583

ABSTRACT

In embryonic development, pure cartilage structures are in the basis of bone-cartilage interfaces. Despite this fact, the mature bone and cartilage structures can vary greatly in composition and function. Nevertheless, they collaborate in the osteochondral region to create a smooth transition zone that supports the movements and forces resulting from the daily activities. In this sense, all the hierarchical organization is involved in the maintenance and reestablishment of the equilibrium in case of damage. Therefore, this interface has attracted a great deal of interest in order to understand the mechanisms of regeneration or disease progression in osteoarthritis. With that purpose, in vitro tissue models (either static or dynamic) have been studied. Static in vitro tissue models include monocultures, co-cultures, 3D cultures, and ex vivo cultures, mostly cultivated in flat surfaces, while dynamic models involve the use of bioreactors and microfluidic systems. The latter have emerged as alternatives to study the cellular interactions in a more authentic manner over some disadvantages of the static models. The current alternatives of in vitro mimetic models for bone-cartilage interface regeneration are overviewed and discussed herein.


Subject(s)
Bone Diseases/therapy , Cartilage Diseases/therapy , Cell Culture Techniques , Organ Culture Techniques , Tissue Engineering/methods , Animals , Bioreactors , Bone Diseases/pathology , Bone and Bones/cytology , Bone and Bones/physiology , Cartilage Diseases/pathology , Cartilage, Articular/physiology , Chondrocytes/cytology , Chondrocytes/transplantation , Chondrogenesis/physiology , Coculture Techniques , Humans , Lab-On-A-Chip Devices , Osteogenesis/physiology , Printing, Three-Dimensional , Tissue Scaffolds
3.
Adv Exp Med Biol ; 1058: 415-428, 2018.
Article in English | MEDLINE | ID: mdl-29691833

ABSTRACT

The osteochondral tissue represents a complex structure composed of four interconnected structures, namely hyaline cartilage, a thin layer of calcified cartilage, subchondral bone, and cancellous bone. Due to the several difficulties associated with its repair and regeneration, researchers have developed several studies aiming to restore the native tissue, some of which had led to tissue-engineered commercial products. In this sense, this chapter discusses the good manufacturing practices, regulatory medical conditions and challenges on clinical translations that should be fulfilled regarding the safety and efficacy of the new commercialized products. Furthermore, we review the current osteochondral products that are currently being marketed and applied in the clinical setting, emphasizing the advantages and difficulties of each one.


Subject(s)
Bone Regeneration , Bone Substitutes/therapeutic use , Bone and Bones , Hyaline Cartilage , Regenerative Medicine/methods , Tissue Engineering , Animals , Bone and Bones/injuries , Bone and Bones/metabolism , Bone and Bones/pathology , Humans , Hyaline Cartilage/injuries , Hyaline Cartilage/metabolism , Hyaline Cartilage/pathology
4.
Bioessays ; 39(10)2017 10.
Article in English | MEDLINE | ID: mdl-28787099

ABSTRACT

Peroxisomal matrix proteins are synthesized on cytosolic ribosomes and rapidly transported into the organelle by a complex machinery. The data gathered in recent years suggest that this machinery operates through a syringe-like mechanism, in which the shuttling receptor PEX5 - the "plunger" - pushes a newly synthesized protein all the way through a peroxisomal transmembrane protein complex - the "barrel" - into the matrix of the organelle. Notably, insertion of cargo-loaded receptor into the "barrel" is an ATP-independent process, whereas extraction of the receptor back into the cytosol requires its monoubiquitination and the action of ATP-dependent mechanoenzymes. Here, we review the main data behind this model.


Subject(s)
Peroxisomes/metabolism , Protein Transport/physiology , Animals , Humans , Peroxisomal Targeting Signal 2 Receptor/metabolism , Peroxisome-Targeting Signal 1 Receptor/metabolism , Signal Transduction/physiology , Ubiquitination/physiology
5.
Curr Gene Ther ; 15(6): 541-9, 2015.
Article in English | MEDLINE | ID: mdl-26415574

ABSTRACT

Current influenza vaccines have long been used to fight flu infectious; however, recent advances highlight the importance of produce new alternatives. Even though traditional influenza vaccines are safe and usually effective, they need to be uploaded every year to anticipate circulating flu viruses. This limitation together with the use of embryonated chicken eggs as the substrate for vaccine production, is time-consuming and could involve potential biohazards in growth of new virus strains. Plasmid DNA produced by prokaryote microorganisms and encoding foreign proteins had emerged as a promising therapeutic tool. This technology allows the expression of a gene of interest by eukaryotic cells in order to induce protective immune responses against the pathogen of interest. In this review, we discuss the strategies to choose the best DNA vaccine to be applied in the treatment and prevention of influenza. Specifically, we give an update of influenza DNA vaccines developments, all involved techniques, their main characteristics, applicability and technical features to obtain the best option against influenza infections.


Subject(s)
Hemagglutinins, Viral/genetics , Influenza Vaccines/immunology , Influenza, Human/prevention & control , Plasmids/genetics , Vaccines, DNA/immunology , Hemagglutinins, Viral/immunology , Humans , Influenza Vaccines/adverse effects , Influenza Vaccines/genetics , Influenza, Human/immunology , Influenza, Human/therapy , Plasmids/immunology , Plasmids/therapeutic use , Vaccines, DNA/adverse effects , Vaccines, DNA/genetics
6.
J Sep Sci ; 37(17): 2284-92, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24917044

ABSTRACT

DNA therapies are becoming recognized alternatives for the treatment and prevention of severe pathologies. Although most current trials have used plasmids <10 kbp, in the future larger plasmids would be required. The purpose of this work was to study the chromatographic behavior of nongrafted carbonyldiimidazole monolithic disks using plasmids with different sizes under hydrophobic conditions. Thereunto, the purification of several plasmids was performed. Higher size plasmids needed lower ammonium sulfate concentration, due to the greater number of interactions between the plasmids and monolith. The dynamic binding capacity experiments for the different plasmids revealed a lower capacity for bigger plasmids. It was also verified that the increase of salt concentration from 2.5 to 3 M of ammonium sulfate increased the capacity. At the highest salt concentration, a slight improvement in the capacity using lower flow rate was observed, possibly due to compaction of plasmid molecules and its better organization on the monolith channels. Finally, a low pH also had a positive effect on the capacity. So, this monolithic support proved to be appropriate to purify the supercoiled isoform of different plasmids with different sizes, providing a valuable instrument as a purification technique.


Subject(s)
Chromatography, Affinity/methods , DNA, Superhelical/chemistry , Plasmids/chemistry , Adsorption , Ammonium Sulfate/chemistry , Chromatography, Affinity/instrumentation , DNA, Superhelical/isolation & purification , Hydrophobic and Hydrophilic Interactions , Plasmids/isolation & purification , Resins, Synthetic/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...